ACSM6
Basic information
Region (hg38): 10:95194200-95228929
Previous symbols: [ "C10orf129" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACSM6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 25 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 25 | 1 | 0 |
Variants in ACSM6
This is a list of pathogenic ClinVar variants found in the ACSM6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-95194509-C-A | not specified | Uncertain significance (Dec 15, 2023) | ||
10-95194544-C-G | not specified | Uncertain significance (May 25, 2022) | ||
10-95202004-A-G | not specified | Uncertain significance (Sep 14, 2022) | ||
10-95202009-G-C | not specified | Uncertain significance (Jul 27, 2022) | ||
10-95202016-G-C | not specified | Uncertain significance (Nov 09, 2021) | ||
10-95202021-G-C | not specified | Uncertain significance (Mar 31, 2024) | ||
10-95202084-G-T | not specified | Uncertain significance (Aug 30, 2022) | ||
10-95202117-A-T | not specified | Uncertain significance (Jun 10, 2024) | ||
10-95207256-G-A | not specified | Uncertain significance (Oct 05, 2023) | ||
10-95207272-G-T | not specified | Uncertain significance (Mar 28, 2023) | ||
10-95207330-G-A | not specified | Likely benign (Dec 15, 2021) | ||
10-95210672-T-C | not specified | Uncertain significance (Jan 22, 2024) | ||
10-95211888-G-T | not specified | Uncertain significance (Mar 01, 2023) | ||
10-95211889-A-T | not specified | Uncertain significance (Mar 01, 2023) | ||
10-95211922-G-A | not specified | Uncertain significance (May 25, 2022) | ||
10-95211985-G-C | not specified | Uncertain significance (Feb 28, 2024) | ||
10-95212009-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
10-95212912-G-C | not specified | Uncertain significance (Oct 26, 2022) | ||
10-95214933-C-G | not specified | Uncertain significance (Apr 17, 2024) | ||
10-95214938-A-G | not specified | Uncertain significance (Dec 08, 2021) | ||
10-95214968-C-T | not specified | Uncertain significance (Sep 29, 2022) | ||
10-95219892-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
10-95219946-A-G | not specified | Uncertain significance (Aug 28, 2023) | ||
10-95219964-T-C | not specified | Uncertain significance (Mar 28, 2022) | ||
10-95225320-C-T | not specified | Uncertain significance (Apr 19, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACSM6 | protein_coding | protein_coding | ENST00000341686 | 10 | 34729 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.53e-7 | 0.849 | 125624 | 0 | 124 | 125748 | 0.000493 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.957 | 212 | 255 | 0.831 | 0.0000129 | 3130 |
Missense in Polyphen | 46 | 65.493 | 0.70236 | 797 | ||
Synonymous | 1.99 | 68 | 92.3 | 0.737 | 0.00000471 | 926 |
Loss of Function | 1.54 | 14 | 21.8 | 0.643 | 0.00000100 | 276 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000554 | 0.000554 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00473 | 0.00474 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000159 | 0.000158 |
Middle Eastern | 0.00473 | 0.00474 |
South Asian | 0.000163 | 0.000163 |
Other | 0.000814 | 0.000815 |
dbNSFP
Source:
- Pathway
- Butanoate metabolism - Homo sapiens (human);Metabolism of lipids;Beta oxidation of butanoyl-CoA to acetyl-CoA;mitochondrial fatty acid beta-oxidation of saturated fatty acids;Mitochondrial Fatty Acid Beta-Oxidation;Metabolism;Fatty acid metabolism;γ-linolenate biosynthesis;icosapentaenoate biosynthesis II (metazoa)
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- 0.68
- rvis_percentile_EVS
- 85.04
Haploinsufficiency Scores
- pHI
- 0.0335
- hipred
- N
- hipred_score
- 0.112
- ghis
Gene ontology
- Biological process
- fatty acid biosynthetic process;acyl-CoA metabolic process
- Cellular component
- mitochondrial matrix
- Molecular function
- acyl-CoA ligase activity;fatty-acyl-CoA synthase activity;ATP binding;GTP binding;fatty acid ligase activity;metal ion binding;butyrate-CoA ligase activity